Dow Jones

40 211,72

0,53%

DAX

Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.

S'inscrire

Accueil
Investir
Actions
Etats-Unis
NASDAQ
Allos Therapeutics, Inc. (MM) (ALTH)
Allos Therapeutics, Inc. (MM) (ALTH) Actualités

ALTH

Allos Therapeutics, Inc. (MM) (ALTH)

Allos Therapeutics, Inc. (MM)

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:ALTH

<< Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Suivant >>

Date	Heure	Source	Titre	Symbole	Société
23/05/2008	13h15	Edgar (US Regulatory)	Allos Therapeutics Inc - Free Writing Prospectus - Filing under Securities Act Rules 163/433 (FWP)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
23/05/2008	12h34	Business Wire	Allos Therapeutics Announces Pricing of Public Offering of 10,800,000 Shares of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
19/05/2008	12h45	Edgar (US Regulatory)	Allos Therapeutics Inc - Current report filing (8-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
19/05/2008	12h33	Edgar (US Regulatory)	Allos Therapeutics Inc - Prospectus filed pursuant to Rule 424(b)(5) (424B5)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
19/05/2008	12h41	Business Wire	Allos Therapeutics Announces Public Offering of 9,000,000 Shares of Common Stock	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
15/05/2008	12h00	Business Wire	Allos Therapeutics Reports Interim Response and Safety Data from Pivotal Phase 2 PROPEL Trial	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/05/2008	22h40	Edgar (US Regulatory)	Allos Therapeutics Inc - Quarterly Report (10-Q)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/05/2008	13h30	Business Wire	Allos Therapeutics Reports First Quarter 2008 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
06/05/2008	22h30	Business Wire	Allos Therapeutics to Present at the Bank of America 2008 Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/04/2008	20h24	Edgar (US Regulatory)	Allos Therapeutics Inc - Proxy Statement (definitive) (DEF 14A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
24/04/2008	22h00	Business Wire	Allos Therapeutics to Report 2008 First Quarter Financial Results on May 7, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
22/04/2008	14h00	Business Wire	Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-cell Lympho	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/03/2008	23h06	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Changes in Beneficial Ownership (4)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
27/02/2008	22h54	Edgar (US Regulatory)	Allos Therapeutics Inc - Annual Report (10-K)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
27/02/2008	13h30	Business Wire	Allos Therapeutics Reports 2007 Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
14/02/2008	21h52	Edgar (US Regulatory)	Allos Therapeutics Inc - Amended Statement of Ownership (SC 13G/A)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
14/02/2008	16h54	Edgar (US Regulatory)	Allos Therapeutics Inc - Statement of Ownership (SC 13G)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/02/2008	14h00	Business Wire	Allos Therapeutics to Report 2007 Results on February 27, 2008	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
04/02/2008	21h23	Edgar (US Regulatory)	Allos Therapeutics Inc - Initial Statement of Beneficial Ownership (3)	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/01/2008	14h00	PR Newswire (US)	Allos Therapeutics to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
28/01/2008	14h00	PR Newswire (US)	Allos Therapeutics Appoints Bruce K. Bennett as Vice President, Manufacturing	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/01/2008	14h00	PR Newswire (US)	Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cell Lung Cancer	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
27/12/2007	14h00	PR Newswire (US)	Interim Safety Analysis Supports Continuation of Allos Therapeutics' Pivotal Phase 2 PROPEL Trial of PDX in Patients with Periph	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
11/12/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2008 JPMorgan Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/12/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 RBC Capital Markets Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
29/11/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 BMO Capital Markets Focus on Healthcare Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
20/11/2007	14h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 Lazard Capital Markets Healthcare Investor Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
12/11/2007	22h00	PR Newswire (US)	Allos Therapeutics Initiates Study of RH1 in Patients with Advanced Solid Tumors or non-Hodgkin's Lymphoma	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
07/11/2007	22h00	PR Newswire (US)	Allos Therapeutics to Present at the 2007 JMP Securities Healthcare Focus Conference	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)
05/11/2007	13h30	PR Newswire (US)	Allos Therapeutics Reports Third Quarter 2007 Financial Results	NASDAQ:ALTH	Allos Therapeutics, Inc. (MM)